$1.645
-0.053 (-3.24%)Al cierre
- Máximo
- 1.720
- Apertura
- 1.630
- Precio medio ponderado por volumen
- 1.67
- Volumen
- 6.05K
- Capitalización
- —
- Mínimo
- 1.630
- Importe
- 10.07K
- EV/EBITDA, TTM
- 0.00
iTonic Holdings Ltd, formerly Pheton Holdings Ltd, is a holding company principally engaged in the provision of healthcare solutions through its subsidiary Beijing Feitian Zhaoye Technology Co., Ltd. (Beijing Feitian). The Company’s main businesses include development and commercialization of brachytherapy treatment planning system (TPS) specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. TPS is generally a computer software used in different types of radiotherapy. The Company’s main product is FTTPS, a user-oriented TPS for treating a wide variety of malignant tumors. Beijing Feitian’s product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device and others.
Análisis de IA of iTonic Holdings Ltd (ITOC)
VenderiTonic Holdings Ltd (ITOC) is not a good buy right now due to its extremely low RSI of 16.645, indicating it is oversold, and a staggering year-to-date change of -88.61%.
Métricas de valoración
Cronología de eventos
Noticias
2.009-24PRnewswireClass Action Lawsuit Filed Against iTonic Holdings Ltd
7.009-23PRnewswireiTonic Holdings Faces Securities Class Action Over Disclosure Failures
7.009-15PRnewswireiTonic Holdings Ltd Faces Securities Class Action Over Fraud Allegations
7.009-10PRnewswireClass Action Lawsuit Filed Against iTonic Holdings Ltd
7.009-09PRnewswireiTonic Holdings Faces Class Action Over Disclosure Failures
Preguntas frecuentes sobre ITOC, respondidas por Alphio AI
iTonic Holdings Ltd, formerly Pheton Holdings Ltd, is a holding company principally engaged in the provision of healthcare solutions through its subsidiary Beijing Feitian Zhaoye Technology Co., Ltd. (Beijing Feitian). The Company’s main businesses include development and commercialization of brachytherapy treatment planning system (TPS) specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. TPS is generally a computer software used in different types of radiotherapy. The Company’s main product is FTTPS, a user-oriented TPS for treating a wide variety of malignant tumors. Beijing Feitian’s product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device and others. It operates in the Healthcare sector.
iTonic Holdings Ltd (ITOC) is not a good buy right now due to its extremely low RSI of 16.645, indicating it is oversold, and a staggering year-to-date change of -88.61%.
Comunidad
Más ↗Aún no hay publicaciones
Regístrate o inicia sesión para participarArtículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.